Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system

Journal of Infection

Volumn 53, Issue 1, 2006, Pages

  Tsai, Shih Hung ^a   Chang, Hao Ming ^a   Hsieh, Chung Bao ^a   Chao, You Chen ^a   Hsieh, Tsai Yuan ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Chronic renal failure; Fulminant hepatitis B; Lamivudine; Molecular adsorbent recirculating system (MARS)

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

ACUTE HEPATITIS; ADJUVANT THERAPY; ADULT; ALBUMIN DIALYSIS; ANOREXIA; ANTIBODY TITER; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; DIABETIC NEPHROPATHY; FEVER; HEMODIALYSIS; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; JAUNDICE; LIVER FAILURE; LIVER TRANSPLANTATION; MALAISE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEROCONVERSION;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; HEMODIAFILTRATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER FAILURE, ACUTE; MALE; TREATMENT OUTCOME;

EID: 33745508692     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.09.013     Document Type: Article

References (18)

1. Lee W.M. Acute liver failure in the United States. Semin Liver Dis 23 (2003) 217-226
2. Perrillo R.P., and Mason A.L. Hepatitis B and liver transplantation-problems and promises. N Engl J Med 329 (1993) 1885-1887
3. Hamada T., Kumashiro R., Koga Y., Hino T., Furudera S., Sakisaka S., et al. Fatal acute hepatitis B virus infection while receiving immunosuppressants after renal transplant. Int Med 32 (1993) 547-551
4. Ahmed A., and Keeffe E.B. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol 94 (1999) 249-251
5. Carithers R.L. Liver Transplantation. Liver Transpl 6 (2000) 122-135
6. O'Grady J.G., Alexander G.J.M., Hayllar K.M., and Roger W. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445
7. Bernuau J., Goudeau A., and Poynard T. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6 (1986) 648-651
8. Tygstrup N., and Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 6 (1986) 129-137
9. Jalan R., and Williams R. Improvement in cerebral perfusion after MARS Therapy: further clues about the pathogenesis of hepatic encephalopathy?. Liver Transpl 7 (2001) 713-715
10. Mitzner S.R., Stange J., Klammt S., Peszynski P., Schmidt R., and Noldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critical ill patients with liver failure. J Am Soc Nephrol 12 (2001) S75-S82
11. Chen S., Zhang L., Shi Y., Yang X., and Wang M. Molecular adsorbent recirculating system: clinical experience in patients with liver failure based on hepatitis B in China. Liver 22 (2002) 48-51
12. A Al-Taie O.H., Mork H., Gassel A.H., Wilhelm M., Weissbrich B., and Scheurlen M. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Ann Hematol 78 (1999) 247-249
13. Gareth D., Lisa H., Jon K., and Paul M. Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient. Transplantation 67 (1999) 1288-1289
14. Ganem D., and Prince A.M. Hepatitis B virus infection-natural history and clinical consequence. N Engl J Med 350 (2004) 1118-1129
15. Mutimer D., Pillay D., Shields P., Cane P., Ratcliffe D., Martin B., et al. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut 46 (2000) 102-113
16. Idilman R., Colantoni A., De Maria N., Ustun C., Sam R., Ing T.S., et al. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals. Heaptogastro 50 (2003) 217-221
17. Perrillo R., Rakela J., Dienstag J., Levy G., Martin P., Wright T., et al. Multicenter study of lamivudine therapy for hepatitis B after transplantation. Heaptology 29 (1999) 1581-1586
18. Peters M.G., Singer G., Howard T., Jacobsmeyer S., Xiong X., Gibbs C.S., et al. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient. Durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immunoglobulin. Transplantation 68 (1999) 1912-1914